Biomx
Price & Volume
Stats
See more52W Range | $0.28-$5.60 |
Market Cap | $7.3M |
Shares Short | 44,304 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.95 |
News
See moreYahoo Finance • 11 days ago
BiomX Inc. Announces 1-for-19 Reverse Stock Split
Yahoo Finance • 13 days ago
BiomX outlines imminent FDA feedback and targets BX004 Phase IIb data in Q1 2026 while advancing BX011 for diabetic foot infections
Yahoo Finance • last month
BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways
Yahoo Finance • 3 months ago
BiomX Inc (NYSEARCA:PHGE) Surges 142% After Stunning Q2 2025 Earnings Beat and Promising BX211 Phase 2 Results
About
CEO | Mr. Jonathan Eitan Solomon MBA |
CFO | Ms. Marina Wolfson CPA |
Address | 22 Einstein Street, Ness Ziona, Israel, 7414003 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 52 |
